News und Analysen
![American Express Releases 2020-2021 Environmental, Social, and Governance Report with New Long-Term Goalshttp://upload.wikimedia.org/wikipedia/commons/3/30/American_Express_logo.svg: By CoolKid1993 at en.wikipedia. Later version(s) were uploaded by Tkgd2007 at en.wikipedia. [Public domain], from Wikimedia Commons](https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBYTQ9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--83cded6416037f9828d8e01e5a5ff220c002a735/300px-American_Express_logo.svg?locale=de){kind=logo}
American Express Releases 2020-2021 Environmental, Social, and Governance Report with New Long-Term Goals
American Express (NYSE: AXP) today announced the release of its 2020-2021 Environmental, Social, and Governance (ESG) Report, which includes a new roadmap for the company’s ESG strategy focused on
American Express Releases 2020-2021 Environmental, Social, and Governance Report with New Long-Term Goals
American Express (NYSE: AXP) today announced the release of its 2020-2021 Environmental, Social, and Governance (ESG) Report, which includes a new roadmap for the company’s ESG strategy focused on
Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they have submitted data to the U.S. Food and Drug Administration (FDA) from the Phase 2/3 trial of their COVID-19 vaccine in
Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they have submitted data to the U.S. Food and Drug Administration (FDA) from the Phase 2/3 trial of their COVID-19 vaccine in
Western Union Foundation Funds Education for Underserved Youth
The Western Union Foundation today announced its latest USD 3.7 million Opportunity Beyond Borders investment in skills training, resources, and a new scholarship fund, helping prepare nearly
Dassault Systèmes to Unveil Its Next “Design for Life” Installation at London’s Design Museum
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) (Paris:DSY) today announced the next installation in its “Design for Life” program of collaborations with groundbreaking designers around
Dassault Systèmes to Unveil Its Next “Design for Life” Installation at London’s Design Museum
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) (Paris:DSY) today announced the next installation in its “Design for Life” program of collaborations with groundbreaking designers around
Helmerich & Payne, Inc. Announces Upsize and Pricing of $550 Million Offering of 2.900% Senior Notes due 2031
Helmerich & Payne, Inc. (NYSE:HP) (“H&P” or the “Company”) announced today that it has priced its previously announced private offering (the “Offering”) of $550 million aggregate principal amount
Semtech to Participate in Upcoming Investor Event
Semtech Corporation (Nasdaq: SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, today announced that its Chief Executive Officer, Mohan
Gap Inc. Announces Closing of $1.5 Billion Senior Notes Offering
The Gap, Inc. (NYSE: GPS) (“Gap Inc.” or the “Company”) today announced it has closed its previously announced offering of $1.5 billion of senior notes (the “Notes”), consisting of $750 million
Pfizer Starts Study of mRNA-Based Next Generation Flu Vaccine Program
Pfizer Inc. (NYSE: PFE) announced today that the first participants have been dosed in a Phase 1 clinical trial to evaluate the safety, tolerability, and immunogenicity of a single dose
Pfizer Starts Study of mRNA-Based Next Generation Flu Vaccine Program
Pfizer Inc. (NYSE: PFE) announced today that the first participants have been dosed in a Phase 1 clinical trial to evaluate the safety, tolerability, and immunogenicity of a single dose
PotlatchDeltic Scheduled to Release Third Quarter 2021 Earnings on October 25, 2021
PotlatchDeltic Corporation (Nasdaq: PCH) will release third quarter earnings on Monday, October 25, after the market closes. The company will hold a live conference call and webcast on Tuesday
Chevron Mourns Passing of Former Texaco Chairman Alfred DeCrane
Chevron Corporation today honored the life and career of former Texaco Chairman and CEO Alfred C. DeCrane, Jr., who died this past week at the age of 90.
This press release features multimedia
Chevron Mourns Passing of Former Texaco Chairman Alfred DeCrane
Chevron Corporation today honored the life and career of former Texaco Chairman and CEO Alfred C. DeCrane, Jr., who died this past week at the age of 90.
This press release features multimedia
Keysight Technologies, National Central University Optical Sciences Center, Establish Third-generation Semiconductor R&D and Test Open Laboratory
Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world, and
Helmerich & Payne, Inc. Announces Private Offering of $500 Million of Senior Notes and Conditional Redemption of 4.65% Senior Notes due 2025
Helmerich & Payne, Inc. (NYSE:HP) (“H&P” or the “Company”) announced today that it has commenced a private offering (the “Offering”) of $500 million aggregate principal amount of senior notes due
Gap Inc. Announces Early Tender Results of Cash Tender Offers and Consent Solicitations for Any and All of its Senior Secured Notes
The Gap, Inc. (NYSE: GPS) (“Gap Inc.” or the “Company”) today announced the early tender results of its (i) offers to purchase for cash (collectively, the “Tender Offers” and each a “Tender Offer”)
PulteGroup’s Third Quarter 2021 Earnings Release and Webcast Conference Call Scheduled for October 26, 2021
PulteGroup, Inc. (NYSE: PHM) today announced that it will release its third quarter 2021 financial results before the market opens on Tuesday, October 26, 2021. The Company will hold a conference
Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults
Pfizer Inc. (NYSE: PFE) today announced the start of the Phase 2/3 EPIC-PEP (Evaluation of Protease Inhibition for COVID-19 in Post-Exposure Prophylaxis) study to evaluate the investigational novel
Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults
Pfizer Inc. (NYSE: PFE) today announced the start of the Phase 2/3 EPIC-PEP (Evaluation of Protease Inhibition for COVID-19 in Post-Exposure Prophylaxis) study to evaluate the investigational novel
Hackers help communities combat effects of dangerous floods at Europe's biggest hackathon
Global water technology company, Xylem, today congratulated a team of hackathon participants that has come up with a new way to respond to abrupt flood events. Team Res-Queue won HackZurich 2021’s
PMI Calls for Science-Based Discourse on Smoke-Free Alternatives
Misinformation threatens progress toward a smoke-free future, reveals a new international survey released today by Philip Morris International Inc. (PMI) (NYSE: PM). Well-funded groups continue to
Transplant Genomics Launches OmniGraf™, the Only Combination Biomarker Panel That Provides the Earliest Indication of Rejection in Kidney Transplant Recipients
Transplant Genomics (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide, is pleased to introduce OmniGraf™, which combines the TruGraf®